Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of dexamethasone slow-release system and a kind of osteogenesis differentiation induction liquid and application

A technology of dexamethasone and osteogenic differentiation, which is applied in the field of nanomedicine and regenerative medicine, and can solve problems such as osteogenic differentiation that have not yet been retrieved

Active Publication Date: 2021-09-17
HUNAN UNIV +2
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] At present, there are many reports on the use of dexamethasone for osteogenic differentiation, but most of them are composited with scaffolds (including electrospinning, core-shell PLLACL-collagen fibers, biphasic calcium phosphate nanoparticles / collagen porous composite scaffolds, etc.), Research on the effect of dexamethasone released from various fibrous scaffold materials on osteogenic differentiation, but no reports (including patents or literature) on the use of cyclodextrin / dexamethasone inclusion compound slow-release system for osteogenic differentiation have been retrieved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of dexamethasone slow-release system and a kind of osteogenesis differentiation induction liquid and application
  • A kind of dexamethasone slow-release system and a kind of osteogenesis differentiation induction liquid and application
  • A kind of dexamethasone slow-release system and a kind of osteogenesis differentiation induction liquid and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1: Preparation of Cyclodextrin / dexamethasine Complex (CD / DEX)

[0035] It is weighted 1.1135 g of beta-Cd (1 mmol) in 20 ml of deionized water, heated to 80 ° C in a stirred state, weighing 0.382 g of dexamethasone (1 mmol) in 10 ml of ethanol, then slowly added to heat In the β-CD solution, stirring was continued for 11.0 hours, stop heating, and stirring at room temperature for 24.0 h, and the refrigerator (4 ° C) was placed overnight, filtered, and a small amount of acetone multiple times. The resulting precipitate was frozen to give the coated product.

[0036] From figure 1 It can be seen that these absorption peaks are obvious in the physical mixture, but 1664cm in the cladding -1 Place Feature peak disappeared, 1621cm -1 C = C telescopic vibration disappears, 1299cm -1 The coupling between OH bending vibration and C-O telescopic vibration is disappeared. This makes it possible to determine that the DEX is enclosed in the β-CD cavity.

Embodiment 2

[0037] Example 2: Preparation of β-cyclodextrin / goldenene-dexamethasone adherate (CD / Ad-DEX)

[0038] Diamamic acid (AD-COOH) (0.1378 g, 0.76 mmol) was dissolved in two in the second of the 2- (3-dimethylaminopropyl) -3-ethyl carbon diimide hydrochloride (0.1465 g, 0.76 mmol) In chloromethane (7 mL), 4-dimethylaminopyridine (0.0156 g, 0.13 mmol) and dexamethamol (0.1000 g, 0.25 mmol) were dissolved in dichloromethane (7 ml) at the same time under expanded light. The mixture was stirred for 15 min, and then the mixture was mixed overnight. The final reaction liquid was separated with silica gel, and the expander was mixed with a metallool of 1 to 30 with a mixed solution of dichloromethane, and the position of Ad-DEX was determined by fluorescence, and then methanol and The mixed solution of the dichloromethane mixed solution was separated. After the AD-DEx was separated, the solvent was rotated to dry, and the resulting white product was ad-den. The AD-DEX powder was dissolved...

Embodiment 3

[0040] Example 3: Preparation of induced induction of bone differentiation efficiency of stem cells according to the present invention

[0041] In the commercially available 500ml low sugar DMEM medium, the volume is added to 10% fetal bovine serum, 10 mmol / Lβ-glycyl phosphate, 50 mg / L ascorbic acid, dexamethasone final concentration of 10 -7 Mol / L adhesion, i.e., new induced fluids that increase the bone differentiation efficiency of stem cells.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a dexamethasone slow-release system, an osteogenic differentiation induction solution and application thereof. The dexamethasone slow-release system includes β-cyclodextrin / dexamethasone inclusion compound and β-cyclodextrin One or both of the inclusion complexes of adamantane-dexamethasone. The slow-release system can increase the drug load of dexamethasone and slow down the release of dexamethasone. This dexamethasone sustained-release system can replace the free dexamethasone component in the osteogenic differentiation induction solution (other components remain unchanged). The time of induction can greatly improve the efficiency of stem cells to differentiate into osteoblasts.

Description

Technical field [0001] The invention belongs to the field of nano-medical and regenerative medical technology, and specific to a dexamethasone sustained release system and its preparation and application thereof. Background technique [0002] Stem cells are ideal seed cells that have damage to tissue due to self-renewal and multi-differentiated capabilities. By providing a new technique for clinical treatment of tissue disease and tissue defects by orientation of stem cells. However, stem cells can be differentiated in addition to the tissue cells desired, and they can participate in tissue repair while also differentiation into other types of cells. Therefore, the stem cell differentiation is required to make it possible to distinguish the desired tissue cell or precursor cell. Improve the efficiency of stem cell directional differentiation can improve the effects of tissue repair. [0003] Conventional inducing mesenchymal Stem Cell (MSC) is mainly chemically induced by chemica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/077
CPCC12N5/0654C12N2501/30C12N2506/1353
Inventor 聂和民徐露雷蕾
Owner HUNAN UNIV